Concepedia

Amanda Culp

AC

Statistics

Publications

4

Citations

255

H-Index

4

Active since

2012

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Amanda Culp is an author at Research Triangle Park Foundation specializing in pharmacology, antiviral therapy, and clinical pharmacology.

Publications per year

2012–2015

4

Publications

4

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

Stephen Castellino, Lee Moss, David S. Wagner et al. · Antimicrobial Agents and Chemotherapy · 2013 · 138 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans

Gary D. Bowers, Amanda Culp, Melinda J. Reese et al. · Xenobiotica · 2015 · 52 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Cotransporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance, and Ketoconazole Interaction Studies

James Sigafoos, Gary D. Bowers, Stephen Castellino et al. · Drug Metabolism and Disposition · 2012 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +17

Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1

David Wilfret, Jill Walker, Kimberly K. Adkison et al. · Antimicrobial Agents and Chemotherapy · 2013 · 22 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–4 of 4